Skip to main content
Equibles

NEWBRY · Newbury Pharmaceuticals AB

Use NEWBRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NEWBRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2.2200 SEK -0.0100 (-0.45%) At close · Oct 2
Rebalance outlook locked
Market Cap
70.22M SEK
Shares
30.40M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close2.2200 SEK Open2.2300 SEK Day2.1000–2.2600 SEK 52W close0.8000–3.3100 SEK Avg vol 30d32K DataFeb 2022–Oct 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 0.8000 SEK Now 2.2200 SEK · 57% Range high 3.3100 SEK
vs 200-day avg +31% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
FNSE:NEWBRY -3.9% -7.5% +98.2% -3.9% +93.0%

Exchange listing

Market
FNSE
Ticker
NEWBRY
ISIN
SE0015244884
Security
—
Trading currency
SEK

Company

Website
https://www.newburypharma.com/
Investor relations
https://www.newburypharma.com/investors

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.